| 1. Executive Summary |
| 2. Global Genomics Market Introduction |
| 2.1. Global Genomics Market - Taxonomy |
| 2.2. Global Genomics Market -Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Technology |
| 2.2.3. By Application |
| 2.2.4. By End User |
| 2.2.5. By Region |
| 3. Global Genomics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Genomics Market Dynamic Factors - Impact Analysis |
| 3.6. Global Genomics Market - Competition Landscape |
| 4. Global Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Genomics Market, By Product Type, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 5.1. Reagents and Kits |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software and Services |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Genomics Market, By Technology, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 6.1. Next Generation Sequencing |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Polymerase Chain Reaction |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Nucleic Acid Extraction and Purification |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Microarray |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Genomics Market, By Application, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 7.1. Diagnostics |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Drug Discovery and Development |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Precision/Personalized Medicine |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Genomics Market, By End User, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 8.1. Pharmaceutical and Biotechnology Companies |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Hospitals and Clinics |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic and Government Institutes |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Clinical Research |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global Genomics Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Region, 2023-2029 |
| 10. North America Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Reagents and Kits |
| 10.1.2. Instruments |
| 10.1.3. Software and Services |
| 10.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Next Generation Sequencing |
| 10.2.2. Polymerase Chain Reaction |
| 10.2.3. Nucleic Acid Extraction and Purification |
| 10.2.4. Microarray |
| 10.2.5. Others |
| 10.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Diagnostics |
| 10.3.2. Drug Discovery and Development |
| 10.3.3. Precision/Personalized Medicine |
| 10.3.4. Others |
| 10.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Pharmaceutical and Biotechnology Companies |
| 10.4.2. Hospitals and Clinics |
| 10.4.3. Academic and Government Institutes |
| 10.4.4. Clinical Research |
| 10.4.5. Others |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029 |
| 10.7. North America Genomics Market Dynamics - Trends |
| 11. Europe Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Reagents and Kits |
| 11.1.2. Instruments |
| 11.1.3. Software and Services |
| 11.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Next Generation Sequencing |
| 11.2.2. Polymerase Chain Reaction |
| 11.2.3. Nucleic Acid Extraction and Purification |
| 11.2.4. Microarray |
| 11.2.5. Others |
| 11.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Diagnostics |
| 11.3.2. Drug Discovery and Development |
| 11.3.3. Precision/Personalized Medicine |
| 11.3.4. Others |
| 11.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Pharmaceutical and Biotechnology Companies |
| 11.4.2. Hospitals and Clinics |
| 11.4.3. Academic and Government Institutes |
| 11.4.4. Clinical Research |
| 11.4.5. Others |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029 |
| 11.7. Europe Genomics Market Dynamics - Trends |
| 12. Asia-Pacific Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Reagents and Kits |
| 12.1.2. Instruments |
| 12.1.3. Software and Services |
| 12.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Next Generation Sequencing |
| 12.2.2. Polymerase Chain Reaction |
| 12.2.3. Nucleic Acid Extraction and Purification |
| 12.2.4. Microarray |
| 12.2.5. Others |
| 12.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Diagnostics |
| 12.3.2. Drug Discovery and Development |
| 12.3.3. Precision/Personalized Medicine |
| 12.3.4. Others |
| 12.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Pharmaceutical and Biotechnology Companies |
| 12.4.2. Hospitals and Clinics |
| 12.4.3. Academic and Government Institutes |
| 12.4.4. Clinical Research |
| 12.4.5. Others |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029 |
| 12.7. Asia-Pacific Genomics Market Dynamics - Trends |
| 13. Latin America Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Reagents and Kits |
| 13.1.2. Instruments |
| 13.1.3. Software and Services |
| 13.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Next Generation Sequencing |
| 13.2.2. Polymerase Chain Reaction |
| 13.2.3. Nucleic Acid Extraction and Purification |
| 13.2.4. Microarray |
| 13.2.5. Others |
| 13.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Diagnostics |
| 13.3.2. Drug Discovery and Development |
| 13.3.3. Precision/Personalized Medicine |
| 13.3.4. Others |
| 13.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Pharmaceutical and Biotechnology Companies |
| 13.4.2. Hospitals and Clinics |
| 13.4.3. Academic and Government Institutes |
| 13.4.4. Clinical Research |
| 13.4.5. Others |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029 |
| 13.7. Latin America Genomics Market Dynamics - Trends |
| 14. Middle East and Africa Genomics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
| 14.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Reagents and Kits |
| 14.1.2. Instruments |
| 14.1.3. Software and Services |
| 14.2. Technology Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Next Generation Sequencing |
| 14.2.2. Polymerase Chain Reaction |
| 14.2.3. Nucleic Acid Extraction and Purification |
| 14.2.4. Microarray |
| 14.2.5. Others |
| 14.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Diagnostics |
| 14.3.2. Drug Discovery and Development |
| 14.3.3. Precision/Personalized Medicine |
| 14.3.4. Others |
| 14.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Pharmaceutical and Biotechnology Companies |
| 14.4.2. Hospitals and Clinics |
| 14.4.3. Academic and Government Institutes |
| 14.4.4. Clinical Research |
| 14.4.5. Others |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2023-2029 |
| 14.7. MEA Genomics Market Dynamics - Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Illumina, Inc. |
| 15.2.2. Thermo Fisher Scientific |
| 15.2.3. QIAGEN N.V. |
| 15.2.4. Agilent Technologies, Inc. |
| 15.2.5. F. Hoffmann-La Roche Ltd. |
| 15.2.6. Bio-Rad Laboratories, Inc. |
| 15.2.7. Eurofins Scientific |
| 15.2.8. 10x Genomics |
| 15.2.9. 23andMe, Inc. |
| 15.2.10. PROMEGA CORPORATION |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
Key Features of the Reports
- The report provides granular level information about the market size, regional market share and forecast from 2023-2029
- The report covers in-detail insights about the competitor's overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup's details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Frequently Asked Questions
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Illumina, Inc.
- Thermo Fisher Scientific
- QIAGEN N.V.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific
- MGI Tech Co., Ltd.
- MERCK KGAA
- PROMEGA CORPORATION
- 10x Genomics
- 23andMe, Inc